Academic authorship of journal articles, books, and other original works is a means by which academics communicate the results of their scholarly work, establish priority for their discoveries, and build their reputation among their peers. Through authorship, researchers, assistants, interns, students, and other involved parties (e.g., citizen scientists, academic consortia) receive credit for their contributions and can be held responsible and accountable for the quality and integrity of the work.[1]

Authorship is a primary basis that employers use to evaluate academic personnel for employment, promotion, and tenure. In academic publishing, authorship of a work is typically claimed by those making intellectual contributions to the research described in the work. However, many scholarly journals also require that potential authors contribute to the writing of the article about the work, not just the work itself.[2] Such requirements, as well as other norms around authorship in disciplines, can be controversial. In these contexts, authorship can encompass activities other than writing the article; a researcher who comes up with an experimental design and analyzes the data may be considered an author, even if she or he had little role in composing the text describing the results. According to some standards, even writing the entire article would not constitute authorship unless the writer was also involved in at least one other phase of the project.[3]

Definition

edit

Guidelines for assigning authorship vary between institutions and disciplines.[4] They may be formally defined or simply cultural norms. Incorrect assignment of authorship occasionally leads to charges of academic misconduct and sanctions for the violator. A 2002 survey of a large sample of researchers who had received funding from the U.S. National Institutes of Health revealed that 10% of respondents claimed to have inappropriately assigned authorship credit within the last three years.[5] This was the first large scale survey concerning such issues. In other fields only limited or no empirical data is available.

Authorship in the natural sciences

edit

The natural sciences have no universal standard for authorship, but some major multi-disciplinary journals and institutions have established guidelines for work that they publish. The journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) has an editorial policy that specifies "authorship should be limited to those who have contributed substantially to the work" and furthermore, "authors are strongly encouraged to indicate their specific contributions" as a footnote. The American Chemical Society further specifies that authors are those who also "share responsibility and accountability for the results"[6] and the U.S. National Academies specify "an author who is willing to take credit for a paper must also bear responsibility for its contents. Thus, unless a footnote or the text of the paper explicitly assigns responsibility for different parts of the paper to different authors, the authors whose names appear on a paper must share responsibility for all of it."[7]

Authorship in mathematics

edit

In mathematics, the authors are usually listed in alphabetical order (the so-called Hardy-Littlewood Rule).[8]

Authorship in medicine

edit

The medical field defines authorship very narrowly. According to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, designation as an author must satisfy four conditions. The author must have:

  1. Contributed substantially to the conception and design of the study, the acquisition of data, or the analysis and interpretation
  2. Drafted or provided critical revision of the article
  3. Provided final approval of the version to publish
  4. Agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved

Acquisition of funding, or general supervision of the research group alone does not constitute authorship. Biomedical authorship is prone to various misconducts and disputes.[9] Many authors – especially those in the middle of the byline – do not fulfill these authorship criteria.[10] Some medical journals have abandoned the strict notion of author, with the flexible notion of contributor.[11]

Authorship in the social sciences

edit

The American Psychological Association (APA) has similar guidelines as medicine for authorship. The APA acknowledge that authorship is not limited to the writing of manuscripts, but must include those who have made substantial contributions to a study such as "formulating the problem or hypothesis, structuring the experimental design, organizing and conducting the statistical analysis, interpreting the results, or writing a major portion of the paper".[12] While the APA guidelines list many other forms of contributions to a study that do not constitute authorship, it does state that combinations of these and other tasks may justify authorship. Like medicine, the APA considers institutional position, such as department chair, insufficient for attributing authorship.

Authorship in the humanities

edit

Neither the Modern Languages Association[13] nor the Chicago Manual of Style[14] define requirements for authorship (because usually humanities works are single-authored and the author is responsible for the entire work).

Growing number of authors per paper

edit

From the late 17th century to the 1920s, sole authorship was the norm, and the one-paper-one-author model worked well for distributing credit.[15] Today, shared authorship is common in most academic disciplines,[16][17] with the exception of the humanities, where sole authorship is still the predominant model. Between about 1980-2010 the average number of authors in medical papers increased, and perhaps tripled.[18] One survey found that in mathematics journals over the first decade of the 2000s, "the number of papers with 2, 3 and 4+ authors increased by approximately 50%, 100% and 200%, respectively, while single author papers decreased slightly."[8]

In particular types of research, including particle physics, genome sequencing and clinical trials, a paper's author list can run into the hundreds. In 1998, the Collider Detector at Fermilab (CDF) adopted a (at that time) highly unorthodox policy for assigning authorship. CDF maintains a standard author list. All scientists and engineers working at CDF are added to the standard author list after one year of full-time work; names stay on the list until one year after the worker leaves CDF. Every publication coming out of CDF uses the entire standard author list, in alphabetical order. Other big collaborations, including most particle physics experiments, followed this model.[19]

In large, multi-center clinical trials authorship is often used as a reward for recruiting patients.[20] A paper published in the New England Journal of Medicine in 1993 reported on a clinical trial conducted in 1,081 hospitals in 15 different countries, involving a total of 41,021 patients. There were 972 authors listed in an appendix and authorship was assigned to a group.[21] In 2015, an article in high-energy physics was published describing the measurement of the mass of the Higgs boson based on collisions in the Large Hadron Collider; the article boasted 5,154 authors, the printed author list needed 24 pages.[22]

Large authors lists have attracted some criticism and are believed to negatively affect all existing ethical issues of authorship.[23] They strain guidelines that insist that each author's role be described and that each author is responsible for the validity of the whole work. Such a system treats authorship more as credit for scientific service at the facility in general rather that as an identification of specific contributions.[24] One commentator wrote, "In more than 25 years working as a scientific editor ... I have not been aware of any valid argument for more than three authors per paper, although I recognize that this may not be true for every field."[25] The rise of shared authorship has been attributed to Big Science—scientific experiments that require collaboration and specialization of many individuals.[26]

Alternatively, the increase in multi-authorship is according to a game-theoretic analysis a consequence of the way scientists are evaluated.[27] Scientists are judged by the number of papers they publish, and by the impact of those papers. Both measures are integrated into the most popular single value measure  -index. The  -index correlates with winning the Nobel Prize, being accepted for research fellowships and holding positions at top universities.[28] When each author claims each paper and each citation as his/her own, papers and citations are multiplied by the number of authors. Since it is common and rational to cite own papers more than others, a high number of coauthors increases not only the number of own papers, but also their impact.[29] As result, game rules set by  -index being a decision criterion for success create a zero-sum  -index ranking game, where the rational strategy includes maximizing the number of coauthors up to the majority of the researchers in a field.[27] Data of 189 thousand publications showed that the coauthors' number is strongly correlated with  -index.[30] Hence, the system rewards heavily multi-authored papers. This problem is openly acknowledged, and it could easily be "corrected" by dividing each paper and its citations by the number of authors,[31][32] though this practice has not been widely adopted.

Finally, the rise in shared authorship may also reflect increased acknowledgment of the contributions of lower level workers, including graduate students and technicians, as well as honorary authorship, while allowing for such collaborations to make an independent statement about the quality and integrity of a scientific work.

Order of authors in a list

edit

Rules for the order of multiple authors in a list have historically varied significantly between fields of research.[33] Some fields list authors in order of their degree of involvement in the work, with the most active contributors listed first;[10] other fields, such as mathematics or engineering, sometimes list them alphabetically.[34][35][36] Historically, biologists tended to place a principal investigator (supervisor or lab head) last in an author list whereas organic chemists might have put him or her first.[37] Research articles in high energy physics, where the author lists can number in the tens to hundreds, often list authors alphabetically. In the academic fields of economics, business, finance or particle physics, it is also usual to sort the authors alphabetically.[38]

Three main questions shape the scholarly debate on authorship order.[39] The first concerns the criteria for deciding the sequence of authors’ names (e.g., alphabetical order, arranging names based on the extent of contributions). The second question focuses on how power dynamics influence authorship order, as competition for prestigious positions (e.g., first or last) can create tensions and lead to unfair treatment of less powerful contributors. The third question is about how authorship order impacts perceived responsibility, since the order alone may not clarify individual accountability, especially when seniority or randomized listings obscure who is ultimately responsible for the work's overall integrity.

Although listing authors in order of the involvement in the project seems straightforward, it often leads to conflict. A study in the Canadian Medical Association Journal found that more than two-thirds of 919 corresponding authors disagreed with their coauthors regarding contributions of each author.[40]

Responsibilities of authors

edit

Authors' reputations can be damaged if their names appear on a paper that they do not completely understand or with which they were not intimately involved.[citation needed][41] Numerous guidelines and customs specify that all co-authors must be able to understand and support a paper's major points.[citation needed]

In a notable case, American stem-cell researcher Gerald Schatten had his name listed on a paper co-authored with Hwang Woo-suk. The paper was later exposed as fraudulent and, though Schatten was not accused of participating in the fraud, a panel at his university found that "his failure to more closely oversee research with his name on it does make him guilty of 'research misbehavior.'"[42]

All authors, including co-authors, are usually expected to have made reasonable attempts to check findings submitted for publication. In some cases, co-authors of faked research have been accused of inappropriate behavior or research misconduct for failing to verify reports authored by others or by a commercial sponsor. Examples include the case of Professor Geoffrey Chamberlain named as guest author of papers fabricated by Malcolm Pearce,[43] (Chamberlain was exonerated from collusion in Pearce's deception)[44] and the co-authors of Jan Hendrik Schön at Bell Laboratories. More recent cases include Charles Nemeroff,[45] former editor-in-chief of Neuropsychopharmacology, and the so-called Sheffield Actonel affair.[46]

Additionally, authors are expected to keep all study data for later examination even after publication. Both scientific and academic censure can result from a failure to keep primary data; the case of Ranjit Chandra of Memorial University of Newfoundland provides an example of this.[47] Many scientific journals also require that authors provide information to allow readers to determine whether the authors may have commercial or non-commercial conflicts of interest. Outlined in the author disclosure statement for the American Journal of Human Biology,[48] this is a policy more common in scientific fields where funding often comes from corporate sources. Authors are also commonly required to provide information about ethical aspects of research, particularly where research involves human or animal participants or use of biological material. Provision of incorrect information to journals may be regarded as misconduct. Financial pressures on universities have encouraged this type of misconduct. The majority of recent cases of alleged misconduct involving undisclosed conflicts of interest or failure of the authors to have seen scientific data involve collaborative research between scientists and biotechnology companies.[49]

Egregious and questionable types of authorship

edit

Honorary authorship

edit

Honorary authorship is sometimes granted to those who played no significant role in the work, for a variety of reasons. Until recently, it was standard to list the head of a German department or institution as an author on a paper regardless of input.[37] The United States National Academy of Sciences, however, warns that such practices "dilute the credit due the people who actually did the work, inflate the credentials of those so 'honored,' and make the proper attribution of credit more difficult."[7] The extent to which honorary authorship still occurs is not empirically known. However, it is plausible to expect that it is still widespread, because senior scientists leading large research groups can receive much of their reputation from a long publication list and thus have little motivation to give up honorary authorships.

A possible measure against honorary authorships has been implemented by some scientific journals, in particular by the Nature journals. They demand[50] that each new manuscript must include a statement of responsibility that specifies the contribution of every author. The level of detail varies between the disciplines. Senior persons may still make some vague claim to have "supervised the project", for example, even if they were only in the formal position of a supervisor without having delivered concrete contributions. (The truth content of such statements is usually not checked by independent persons.) However, the need to describe contributions can at least be expected to somewhat reduce honorary authorships. In addition, it may help to identify the perpetrator in a case of scientific fraud.

Gift, guest and rolling authorship

edit

More specific types of honorary authorship are gift, guest and rolling authorship. Gift authorship consists of authorship obtained by the offer of another author (honorary or not) with objectives that are beyond the research article itself or are ulterior, as promotion or favor.[51] Guest authors are those that are included with the specific objective to increase the probability that it becomes accepted by a journal. A rolling authorship is a special case of gift authorship in which the honor is granted on the basis of previous research papers (published or not) and collaborations within the same research group.[citation needed] The "rolled" author may (or may not) be imposed by a superior employee for reasons that range from the research group's strategic interests, personal career interests, camaraderie or (professional) concession. For instance, a post-doc researcher in the same research group where his PhD was awarded, may be willing to roll his authorship into any subsequent paper from other researchers in that same group, overseeing the criteria for authorship. Per se, this would not cause authorship issues unless the collaboration was imposed by a third party, like a supervisor or department manager, in which case it is called a coercive authorship.[52] Still, omitting the authorship criteria by prioritizing hierarchy arguments, is an unethical practice. This kind of practices may hinder free-thinking and professional independence, and thus should be tackled by research managers, clear research guidelines and authors agreements.

Ghost authorship

edit

Ghost authorship occurs when an individual makes a substantial contribution to the research or the writing of the report, but is not listed as an author.[53] Researchers, statisticians and writers (e.g. medical writers or technical writers) become ghost authors when they meet authorship criteria but are not named as an author. Writers who work in this capacity are called ghostwriters.

Ghost authorship has been linked to partnerships between industry and higher education. Two-thirds of industry-initiated randomized trials may have evidence of ghost authorship.[53] Ghost authorship is considered problematic because it may be used to obscure the participation of researchers with conflicts of interest.[54]

Litigation against the pharmaceutical company, Merck over health concerns related to use of their drug, Rofecoxib (brand name Vioxx), revealed examples of ghost authorship.[55] Merck routinely paid medical writing companies to prepare journal manuscripts, and subsequently recruited external, academically affiliated researchers to pose as the authors.

Authors are sometimes included in a list without their permission.[56] Even if this is done with the benign intention to acknowledge some contributions, it is problematic since authors carry responsibility for correctness and thus need to have the opportunity to check the manuscript and possibly demand changes.

Fraudulent paid-for authorship

edit

Researchers can pay to intentionally and dishonestly list themselves as authors on papers they have not contributed to, usually by using an academic paper mill which specializes in authorship sales.[57]

Unconventional types of authorship

edit

Anonymous and unclaimed authorship

edit

Authors occasionally forgo claiming authorship, for a number of reasons. Historically some authors have published anonymously to shield themselves when presenting controversial claims. A key example is Robert Chambers' anonymous publication of Vestiges of the Natural History of Creation, a speculative, pre-Darwinian work on the origins of life and the cosmos. The book argued for an evolutionary view of life in the same spirit as the late Frenchman Jean-Baptiste Lamarck. Lamarck had long been discredited among intellectuals by this time and evolutionary (or development) theories were exceedingly unpopular, except among the political radicals, materialists, and atheists – Chambers hoped to avoid Lamarck's fate.

In the 18th century, Émilie du Châtelet began her career as a scientific author by submitting a paper in an annual competition held by the French Academy of Sciences; papers in this competition were submitted anonymously. Initially presenting her work without claiming authorship allowed her to have her work judged by established scientists while avoiding the bias against women in the sciences. She did not win the competition, but eventually her paper was published alongside the winning submissions, under her real name.[58]

Scientists and engineers working in corporate and military organizations are often restricted from publishing and claiming authorship of their work because their results are considered secret property of the organization that employs them. One notable example is that of William Sealy Gosset, who was forced to publish his work in statistics under the pseudonym "Student" due to his employment at the Guinness brewery. Another account describes the frustration of physicists working in nuclear weapons programs at the Lawrence Livermore Laboratory – years after making a discovery they would read of the same phenomenon being "discovered" by a physicist unaware of the original, secret discovery of the phenomenon.[59]

Satoshi Nakamoto is a pseudonym of a still unknown author or authors' group behind a white paper about bitcoin.[60][61][62][63]

Group authorship

edit

Group authorship, also known as corporate, team, or consortium authorship, involves listing a collective entity (e.g., team, project, corporation, or consortium) as the author in the byline. While group authorships can reduce conflicts over authorship order and the criteria for including or excluding individuals, they also presents challenges, such as ethical concerns over credit and responsibility, legal issues related to copyright, and technical difficulties due to the absence of persistent identifiers such as ORCID for groups.[64]

Equal co-authorship

edit

Equal co-authorship refers to crediting multiple authors as having made "equal contributions" to a paper, often as co-first or co-corresponding authors. This practice has become more common in recent years. Despite its rise, equal co-authorship presents ethical and practical challenges. For instance, it can be difficult to assess whether contributions were truly equal, and tensions might arise about whose name should appear first (the sequence of equal authors).[65] Some argue that equal co-authorship helps resolve tensions and offers fair recognition of significant contributions, especially in collaborative projects.[66] However, even in truly equal scenarios, one author often becomes more prominent, leading to additional complexities about authorship order and responsibilities.[67] The inconsistent recognition of equal co-authorship by journals and academic institutions, along with the lack of standardized policies, further complicates its evaluation in tenure, promotion, and funding decisions.[68]

Non-human authorship

edit

Artificial intelligence systems have been credited with authorship on a handful of academic publications,[69] however, many publishers disallow this on the grounds that "they cannot take responsibility for the content and integrity of scientific papers".[70]

See also

edit

References

edit
  1. ^ Shamoo, Adil E.; Resnik, David B. (2022). Responsible conduct of research (Fourth ed.). New York, NY: Oxford University Press. ISBN 978-0-19-754712-0.
  2. ^ Holcombe, Alex O. (2 July 2019). "Contributorship, Not Authorship: Use CRediT to Indicate Who Did What". Publications. 7 (3): 48. doi:10.3390/publications7030048.
  3. ^ Dickson, J. G.; Conner, R. N.; Adair, K. T. (1978). "Guidelines for Authorship of Scientific Articles". Wildl. Soc. Bull. 6 (4): 260–261. JSTOR 3781489.
  4. ^ Hosseini, Mohammad; Lewis, Jonathan (17 February 2020). "The norms of authorship credit: Challenging the definition of authorship in The European Code of Conduct for Research Integrity". Accountability in Research. 27 (2): 80–98. doi:10.1080/08989621.2020.1721288. ISSN 0898-9621. PMID 31976754.
  5. ^ Martinson, Brian C.; Anderson, MS; De Vries, R (2005). "Scientists behaving badly". Nature. 435 (7043): 737–8. Bibcode:2005Natur.435..737M. doi:10.1038/435737a. PMID 15944677. S2CID 4341622.
  6. ^ "Ethical Guidelines to Publication of Chemical Researchnals, books, and references published by the American Chemical Society" (PDF). pubs.acs.org. American Chemical Society. 2015. Retrieved 26 September 2020.
  7. ^ a b National Academy of Sciences; National Academy of Engineering; Institute of Medicine (27 March 2009). On Being a Scientist: A Guide to Responsible Conduct in Research: Third Edition. nap.edu. doi:10.17226/12192. ISBN 978-0-309-11970-2. PMID 25009901. S2CID 89187225.
  8. ^ a b The Culture of Research and Scholarship in Mathematics: Joint Research and Its Publication (pdf) (Report). American Mathematical Society. 2015.
  9. ^ Astaneh, Behrooz; Schwartz, Lisa; Guyatt, Gordon (15 August 2021). "Biomedical Authorship: Common Misconducts and Possible Scenarios for Disputes". Journal of Academic Ethics. 19 (4): 455–464. doi:10.1007/s10805-021-09435-z. S2CID 238683430.
  10. ^ a b Sauermann, Henry; Haeussler, Carolin (2017). "Authorship and contribution disclosures". Science Advances. 3 (11): e1700404. Bibcode:2017SciA....3E0404S. doi:10.1126/sciadv.1700404. PMC 5687853. PMID 29152564.
  11. ^ Rennie, D.; Yank, V.; Emanuel, L. (1997). "When authorship fails. A proposal to make contributors accountable". JAMA: The Journal of the American Medical Association. 278 (7): 579–85. doi:10.1001/jama.1997.03550070071041. PMID 9268280.
  12. ^ American Psychological Association. (2001). Publication manual of the American Psychological Association (5th ed.). Washington, DC: American Psychological Association. p. 350
  13. ^ Gibaldi, J. (1998). MLA style manual and guide to scholarly publishing (2nd ed.). New York: Modern Language Association of America.
  14. ^ The Chicago Manual of Style (15th ed.). Chicago: University of Chicago Press. 2006. ISBN 978-0226104041.
  15. ^ Greene, Mott (2007). "The demise of the lone author". Nature. 450 (7173): 1165. Bibcode:2007Natur.450.1165G. doi:10.1038/4501165a. PMID 18097387. S2CID 4415697.
  16. ^ Tilak, G; Prasad, V; Jena, A B (2015). "Authorship Inflation in Medical Publications". Inquiry. 52: 0046958015598311. doi:10.1177/0046958015598311. PMC 4943864. PMID 26228035.
  17. ^ Bautista, L M; Pantoja, J C (2000). "A bibliometric synthesis of the recent literature in ornithology and the journal Ardeola" (PDF). Ardeola. 47: 109–121.
  18. ^ Tsao, CI; Roberts, LW (2009). "Authorship in scholarly manuscripts: practical considerations for resident and early career physicians". Academic Psychiatry. 33 (1): 76–9. doi:10.1176/appi.ap.33.1.76. PMID 19349451. S2CID 11245852.
  19. ^ Christopher King (July 2012). "Multiauthor Papers: Onward and Upward". ScienceWatch Newsletter. Retrieved 6 December 2017.
  20. ^ Regalado, A. (1995). "Multiauthor papers on the rise". Science. 268 (5207): 25. Bibcode:1995Sci...268...25R. doi:10.1126/science.7701334. PMID 7701334.
  21. ^ GUSTO investigators (1993). "An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction". The New England Journal of Medicine. 329 (10): 673–82. doi:10.1056/NEJM199309023291001. hdl:1765/5468. PMID 8204123.
  22. ^ Castelvecchi, Davide (2015). "Physics paper sets record with more than 5,000 authors". Nature. doi:10.1038/nature.2015.17567. S2CID 187657002.
  23. ^ Hosseini, Mohammad; Lewis, Jonathan; Zwart, Hub; Gordijn, Bert (23 May 2022). "An Ethical Exploration of Increased Average Numbers of Authors Per Publication". Science and Engineering Ethics. 28 (3): 25. doi:10.1007/s11948-021-00352-3. ISSN 1471-5546. PMC 9126105. PMID 35606542.
  24. ^ Biagioli, M. Rights or rewards? Changing frameworks of scientific authorship. In Scientific Authorship, Biagioli, M. and Galison, P. eds. Routledge, New York, 2003, pp. 253–280.
  25. ^ Van Loon, A. J. (1997). "Pseudo-authorship". Nature. 389 (6646): 11. Bibcode:1997Natur.389...11V. doi:10.1038/37855. PMID 9288957.
  26. ^ Price, Derek John de Solla (1986). "Collaboration in an Invisible College" (PDF). Little science, big science...and beyond. New York: Columbia University Press. pp. 119–134. ISBN 978-0-231-04956-6.
  27. ^ a b Tagiew, Rustam; Ignatov, Dmitry I. (17 September 2017). "Behavior Mining in h-index Ranking Game". Mpra Paper. University Library of Munich, Germany.
  28. ^ Bornmann, Lutz; Daniel, Hans-Dieter (July 2007). "What do we know about the h-index?". Journal of the American Society for Information Science and Technology. 58 (9): 1381–1385. doi:10.1002/asi.20609. S2CID 31323195.
  29. ^ Noorden, Richard Van; Chawla, Dalmeet Singh (19 August 2019). "Hundreds of extreme self-citing scientists revealed in new database". Nature. 572 (7771): 578–579. Bibcode:2019Natur.572..578V. doi:10.1038/d41586-019-02479-7. PMID 31455906. S2CID 201704279.
  30. ^ Batista, Pablo D.; Campiteli, Mônica G.; Kinouchi, Osame (July 2006). "Is it possible to compare researchers with different scientific interests?". Scientometrics. 68 (1): 179–189. arXiv:physics/0509048. doi:10.1007/s11192-006-0090-4. S2CID 34858423.
  31. ^ Põder E (2010). "Let's correct that small mistake". J. Am. Soc. Inform. Sci. Tech. 61 (12): 2593–2594. doi:10.1002/asi.21438.
  32. ^ Lozano, G. A. (2013). "The elephant in the room: multi-authorship and the assessment of individual researchers". Current Science. 105 (4): 443–445. arXiv:1307.1330.
  33. ^ Kennedy, Donald (1985). "On Academic Authorship (RPH 2.8)". Stanford University Research Policy Handbook Document 2.8. Retrieved 1 April 2010.
  34. ^ Stubbs, C. (1997). "The serious business of listing authors". Nature. 388 (6640): 320. Bibcode:1997Natur.388Q.320.. doi:10.1038/40958. PMID 9237742.
  35. ^ "Rules for submission of abstracts to EPAC96". European Particle Accelerator Conference 1996 (EPAC'96). 1995. Archived from the original on 2 July 2012. Retrieved 20 April 2012. Authors to be listed in alphabetical order, all letters capitalized, principal author underlined.
  36. ^ "Guidelines for the Preparation of Abstracts". seventh biennial International Conference on Accelerator and Large Experimental Physics Control Systems (ICALEPCS'99). 1998. Archived from the original on 2 July 2012. Retrieved 20 April 2012. Authors names in capital letters, in alphabetical order, principal author underlined.
  37. ^ a b "Credit where credit's due". Nature. 440 (7084): 591–708. 2006. Bibcode:2006Natur.440..591.. doi:10.1038/440591a. PMID 16572137.
  38. ^ Waltman, L (2012). "An empirical analysis of the use of alphabetical authorship in scientific publishing". Journal of Informetrics. 4 (6): 700–711. arXiv:1206.4863. doi:10.1016/j.joi.2012.07.008. S2CID 12087596.
  39. ^ Hosseini, Mohammad; Gordijn, Bert (3 July 2020). "A review of the literature on ethical issues related to scientific authorship". Accountability in Research. 27 (5): 284–324. doi:10.1080/08989621.2020.1750957. ISSN 0898-9621. PMID 32243214.
  40. ^ Ilakovac V, Fister K, Marusic M, Marusic A (January 2007). "Reliability of disclosure forms of authors' contributions". Canadian Medical Association Journal. 176 (1): 41–6. doi:10.1503/cmaj.060687. PMC 1764586. PMID 17200389.
  41. ^ Bird, Stephanie; Hosseini, Mohammad; Plemmons, Dena (2023). Authors Without Borders: Guidelines for Discussing Authorship with Collaborators. Research Triangle Park, NC: Sigma Xi, The Scientific Research Honor Society. ISBN 979-8-218-31055-4.
  42. ^ Holden, Constance. (2006.) Schatten: Pitt Panel Finds "Misbehavior" but Not Misconduct. Science, 311:928.
  43. ^ Lock S (June 1995). "Lessons from the Pearce affair: handling scientific fraud". BMJ (Clinical Research Ed.). 310 (6994): 1547–8. doi:10.1136/bmj.310.6994.1547. PMC 2549935. PMID 7787632.
  44. ^ "Independent Committee of Inquiry into the publication of articles in the British Journal of Obstetrics and Gynaecology (1994-1995)". Archived from the original on 30 March 2012. Retrieved 26 August 2011.
  45. ^ "Journal editor quits in conflict scandal – The Scientist – Magazine of the Life Sciences". Retrieved 1 April 2010.
  46. ^ "Actonel Case Media Reports – Scientific Misconduct Wiki". Retrieved 1 April 2010.
  47. ^ "Memorial University to re-examine Chandra case". cbc.ca. Retrieved 3 November 2015.
  48. ^ "American Journal of Human Biology – Wiley InterScience". Retrieved 1 April 2010.[dead link]
  49. ^ Washburn, Jennifer (22 December 2005). "Did a British university sell out to P&G? – By Jennifer Washburn – Slate Magazine". Slate Magazine. Archived from the original on 23 March 2010. Retrieved 1 April 2010.
  50. ^ "Authorship: authors & referees @ Nature Publishing Group". Archived from the original on 30 March 2010. Retrieved 1 April 2010.
  51. ^ Harvey, LA (2018). "Gift, honorary or guest authorship". Spinal Cord. 56 (2): 91. doi:10.1038/s41393-017-0057-8. PMID 29422533. S2CID 46803021.
  52. ^ Aliukonis, V; Poškutė, M; Gefenas, E (2020). "Perish or Publish Dilemma: Challenges to Responsible Authorship". Medicina. 56 (2): 91. doi:10.3390/medicina56030123. PMC 7142498. PMID 29422533. S2CID 46803021.
  53. ^ a b Gøtzsche, P.C.; Hróbjartsson, A.; Johansen, H.K.; Haahr, M.T.; Altman, D.G.; Chan, A.-W. (2007). "Ghost authorship in industry-initiated randomised trials". PLOS Medicine. 4 (1): 47–52. doi:10.1371/journal.pmed.0040019. PMC 1769411. PMID 17227134.
  54. ^ Nylenna M, Andersen D, Dahlquist G, Sarvas M, Aakvaag A (July 1999). "Handling of scientific dishonesty in the Nordic countries. National Committees on Scientific Dishonesty in the Nordic Countries". The Lancet. 354 (9172): 57–61. doi:10.1016/S0140-6736(98)07133-5. PMID 10406378. S2CID 36326829.
  55. ^ Ross, Joseph S.; Hill, Kevin P.; Egilman, David S.; Krumholz, Harlan M. (2008). "Guest Authorship and Ghostwriting in Publications Related to Rofecoxib: A Case Study of Industry Documents from Rofecoxib Litigation". JAMA: The Journal of the American Medical Association. 299 (15): 1800–12. doi:10.1001/jama.299.15.1800. PMID 18413874. S2CID 205101269.
  56. ^ "Authorship without authorization". Nature Materials. 3 (11): 743. 2004. Bibcode:2004NatMa...3..743.. doi:10.1038/nmat1264. PMID 15516947.
  57. ^ Abalkina, Anna (October 2023). "Publication and collaboration anomalies in academic papers originating from a paper mill: Evidence from a Russia-based paper mill". Learned Publishing. 36 (4): 689–702. arXiv:2112.13322. doi:10.1002/leap.1574. Retrieved 30 May 2024.
  58. ^ Terrall, M. The uses of anonymity in the age of reason. In Scientific Authorship Biagioli, M. and Galison, P. eds. Routledge, New York, 2003, pp. 91–112.
  59. ^ Gusterson, H. The death of the authors of death – Prestige and creativity among nuclear weapons scientists. In Scientific Authorship Biagioli, M. and Galison, P. eds. Routledge, New York, 2003, pp. 282–307.
  60. ^ "The misidentification of Satoshi Nakamoto". theweek.com. 30 June 2015. Retrieved 22 July 2019.
  61. ^ Kharif, Olga (23 April 2019). "John McAfee Vows to Unmask Crypto's Satoshi Nakamoto, Then Backs Off". Bloomberg.
  62. ^ "Who Is Satoshi Nakamoto, Inventor of Bitcoin? It Doesn't Matter". Fortune. Retrieved 22 July 2019.
  63. ^ Bearman, Sophie (27 October 2017). "Bitcoin's creator may be worth $6 billion – but people still don't know who it is". CNBC. Retrieved 22 July 2019.
  64. ^ Hosseini, Mohammad; Holcombe, Alex O.; Kovacs, Marton; Zwart, Hub; Katz, Daniel S.; Holmes, Kristi (6 March 2024). "Group authorship, an excellent opportunity laced with ethical, legal and technical challenges". Accountability in Research: 1–23. doi:10.1080/08989621.2024.2322557. ISSN 0898-9621. PMC 11377859. PMID 38445637.
  65. ^ Hosseini, Mohammad (1 June 2020). "Equal Co-authorship Practices: Review and Recommendations". Science and Engineering Ethics. 26 (3): 1133–1148. doi:10.1007/s11948-020-00183-8. ISSN 1471-5546. PMID 31989381.
  66. ^ Hosseini, Mohammad; Bruton, Samuel V. (16 November 2020). "A qualitative study of Equal Co-First Authorship". Accountability in Research. 27 (8): 496–520. doi:10.1080/08989621.2020.1776122. ISSN 0898-9621.
  67. ^ Alfonso, Fernando; Zelveian, Parounak; Monsuez, Jean-Jacques; Aschermann, Michael; Böhm, Michael; Hernandez, Alfonso Buendia; Wang, Tzung-Dau; Cohen, Ariel; Izetbegovic, Sebija; Doubell, Anton; Echeverri, Dario; Enç, Nuray; Ferreira-González, Ignacio; Undas, Anetta; Fortmüller, Ulrike; Gatzov, Plamen; Ginghina, Carmen; Goncalves, Lino; Addad, Faouzi; Hassanein, Mahmoud; Heusch, Gerd; Huber, Kurt; Hatala, Robert; Ivanusa, Mario; Lau, Chu-Pak; Marinskis, Germanas; Cas, Livio Dei; Rochitte, Carlos Eduardo; Nikus, Kjell; Fleck, Eckart; Pierard, Luc; Obradović, Slobodan; del Pilar Aguilar Passano, María; Jang, Yangsoo; Rødevand, Olaf; Sander, Mikael; Shlyakhto, Evgeny; Erol, Çetin; Tousoulis, Dimitris; Ural, Dilek; Piek, Jan J.; Varga, Albert; Flammer, Andreas J.; Mach, François; Dibra, Alban; Guliyev, Faiq; Mrochek, Alexander; Rogava, Mamanti; Guzman Melgar, Ismael; Di Pasquale, Giuseppe; Kabdrakhmanov, Kanat; Haddour, Laila; Fras, Zlatko; Held, Claes; Shumakov, Valentyn; Editors’ Network, European Society of Cardiology (ESC) Task Force (1 July 2019). "Authorship: from credit to accountability. Reflections from the Editors' Network". Clinical Research in Cardiology. 108 (7): 723–729. doi:10.1007/s00392-019-01436-8. ISSN 1861-0692.
  68. ^ Resnik, David B.; Smith, Elise; Master, Zubin; Shi, Min (2 April 2020). "Survey of equal contributions in biomedical research publications". Accountability in Research. 27 (3): 115–137. doi:10.1080/08989621.2020.1722947. ISSN 0898-9621. PMC 7065943. PMID 31986059.
  69. ^ Hosseini, Mohammad; Resnik, David B; Holmes, Kristi (October 2023). "The ethics of disclosing the use of artificial intelligence tools in writing scholarly manuscripts". Research Ethics. 19 (4): 449–465. doi:10.1177/17470161231180449. ISSN 1747-0161.
  70. ^ Stokel-Walker, Chris (26 January 2023). "ChatGPT listed as author on research papers: many scientists disapprove". Nature. Springer Nature. Retrieved 31 January 2023.

Further reading

edit